KAYLEE LIVENGOOD: Open Payments
NPI 1891483889 · OAKLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$169 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $169
Food & beverage: $169
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Amgen Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
| Boston Scientific Corporation | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
Products named: AIRSUPRA, JARDIANCE, OTEZLA, FREESTYLE LIBRE 3, WATCHMAN FLX, Dexcom G6 Transmitter, Ozempic.
Industry payments across MD — which companies pay providers there.
